Company news
Tvardi Therapeutics, Inc. news in 2024
Tvardi Therapeutics, Inc.'s news releases, calls and decks from 2024, newest first.
Cara Therapeutics Announces Effective Date of 1-for-12 Reverse Stock Split
December 26, 2024
Cara Therapeutics and Tvardi Therapeutics Announce Entry into Merger Agreement
December 17, 2024
Cara Therapeutics Announces Exploration of Strategic Alternatives
July 10, 2024
Cara Therapeutics Announces Outcome of Part A of KOURAGE-1 Study Evaluating Oral Difelikefalin in Notalgia Paresthetica
June 11, 2024
Cara Therapeutics Reports First Quarter 2024 Financial Results
May 12, 2024
Cara Therapeutics to Announce First Quarter 2024 Financial Results on May 13, 2024
May 5, 2024
Cara Therapeutics to Present at the 23rd Annual Needham Virtual Healthcare Conference
April 1, 2024
Cara Therapeutics to Host Notalgia Paresthetica (NP) Virtual KOL Event on Wednesday, March 27, 2024
March 6, 2024
Cara Therapeutics Announces Fourth Quarter and Full Year 2023 Financial Results
March 3, 2024
Cara Therapeutics to Announce Fourth Quarter and Full Year 2023 Financial Results on March 4, 2024
February 11, 2024
Cara Therapeutics Prioritizes Late-Stage Notalgia Paresthetica Program and Extends Cash Runway into 2026
January 21, 2024
Calls in 2024
Decks in 2024
- Cara Therapeutics — Merger or Acquisition (December 2024)
Merger or acquisition · 31 slides · Dec 20, 2024
- Cara Therapeutics — Merger or Acquisition (December 2024)
Merger or acquisition · 31 slides · Dec 18, 2024